Sort   by:  
 Page size 
UnknownHigh burden of clonal hematopoiesis in first responders exposed to the World Trade Center disaster.
Not available
S-EPMC9394171 | biostudies-literature
UnknownUtilization of COVID-19 Treatments and Clinical Outcomes among Patients with Cancer: A COVID-19 and Cancer Consortium (CCC19) Cohort Study.
Not available
S-EPMC7541683 | biostudies-literature
UnknownAssociation of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.
Not available
S-EPMC7972830 | biostudies-literature
UnknownManagement of Patients with Advanced Prostate Cancer. Part I: Intermediate-/High-risk and Locally Advanced Disease, Biochemical Relapse, and Side Effects of Hormonal Treatment: Report of the Advanced Prostate Cancer Consensus Conference 2022.
Not available
S-EPMC7614721 | biostudies-literature
UnknownCharacterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.
Not available
S-EPMC10841479 | biostudies-literature
UnknownA meta-analysis identifies new loci associated with body mass index in individuals of African ancestry.
Not available
S-EPMC3694490 | biostudies-literature
UnknownGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Not available
S-EPMC4835977 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownConvalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Not available
S-EPMC8121538 | biostudies-literature
UnknownBaricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
Not available
S-EPMC9333998 | biostudies-literature
Sort   by:  
 Page size